Add like
Add dislike
Add to saved papers

Phenotypic and genetic characterization of β-lactam resistance in Klebsiella from retail chicken meat in Mansoura, Egypt.

Background and Objectives: This study was undertaken to characterize antimicrobial resistance phenotypes and genes encoding extended spectrum β-lactamases (ESBLs) in Klebsiella isolated from retail chicken meat in Mansoura, Egypt.

Materials and Methods: Three hundred sixty chicken meat samples from 120 eviscerated chicken carcasses (3 cuts each) collected randomly from local retail chicken shops in Mansoura, Egypt during the period from April to June 2015, were assayed for the presence of Klebsiella by conventional bacteriological methods. Antimicrobial sensitivity for 12 antimicrobials using disk diffusion, ESBL phenotypic confirmation and PCR characterization of ESBL-encoding genes ( bla TEM , bla CTX-M , bla OXA , bla SHV and bla CMY ) were performed.

Results: Klebsiella was identified from 22.2% (80/360) of the samples. Of the 12 antimicrobials tested, multidrug resistance (MDR; resistance to ≥3 of the antimicrobial classes) was observed in 96.25% (77/80) of the Klebsiella isolates. All the isolates were resistant to cefotaxime, ceftriaxone and aztreonam. ESBL-producers were phenotypically confirmed in 48.75% (39/80) of the isolates. The highest values (0.75 and 0.67) of multiple antibiotic resistance (MAR) significantly occurred in ESBL-producing isolates. PCR findings showed a significantly higher occurrence of β-lactamase encoding genes in ESBL (94.9%, 37/39) than non-ESBL producing isolates (4.9%, 2/41). The distribution of bla TEM , bla CTX-M and bla OXA among ESBL-producing isolates was 84.6%, 30.8% and 25.6%, respectively.

Conclusion: Efficient monitoring and tracking of MDR, especially β-lactam resistance, in food sources is essential to predict the potential hazards for human infections.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app